Mumbai, July 12 The BrihanMumbai Municipal Corporation on Monday said that a new 'Antibodies Cocktail Treatment' combining two drugs has apparently worked wonders on Covid-19 patients, as per trials conducted recently.
A mixture of the two drugs - Casirivimab and Indevimab, both manufactured by the pharma giant Roche India - was administered to 212 patients above the age of 12 - and the results of the pilot project are extremely encouraging, Seven Hills Hospital's Dean Dr Balkrishna Adsul said.
"The patients were selected carefully, with their weight above 40 kg, with mild-to-medium symptoms of Covid-19, and at least one co-morbidity condition. They were administered the 'antibodies cocktail' for an hour through saline under medical supervision," he said.
"Most importantly, it can be administered to patients having diabetes, high blood pressure, kidney problems, heart diseases, asthma and other acute respiratory diseases, sickle cell, cerebral palsy, etc" he added.
The results of 199 of the 212 patients' response to the 'antibody cocktail' therapy have been received, with pleasant surprise for the civic and medical authorities.
None of the patients have exhibited any side-effects and their body temperatures
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor